Remove Blog Remove Informed Consent Remove Licensing Remove Regulatory Compliance
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

This year’s Drug & Device Law Blog top ten decisions of the year reinforced preemption – the most powerful defense we can assert. Plaintiff knew about it, too, since he signed an informed consent document mentioning it. They excluded bogus expert testimony under Fed. The device labeling specifically mentioned it. Strike one.

FDA 105